VeriMomБезопасен ли decursinol при беременности?
No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
Related ingredients
Frequently asked questions
- Безопасен ли decursinol при беременности?
- No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- Безопасен ли decursinol при грудном вскармливании?
- No data were found showing transfer into milk, human lactation exposure, or reproductive classification for decursinol. No regulatory (CIR/SCCS/harmonised CLP) guidance or clinical reports were identified to indicate a breastfeeding hazard. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- Безопасен ли decursinol для кожи малыша?
- No infant‑specific safety or dermal‑absorption studies were located. Adult topical cosmetic exposure literature/regulatory sources are absent; because decursinol is a small lipophilic coumarin derivative with measurable bioactivity and dermal use in research contexts, neonatal/infant skin exposure is conservatively assigned higher exposure (+1) due to immature barrier and higher surface‑area:weight; no evidence was found to increase hazard or mechanism scores for infants. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19228635/?utm_source=openai))
- Как VeriMom оценивает decursinol?
- VeriMom оценивает decursinol в 87/100 (низкий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы decursinol при беременности?
- См. наш список безопасных альтернатив decursinol с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.